Skip to main content
Top
Published in:

01-10-2019 | Atrial Fibrillation | Case report

Eptacog-alfa/rivaroxaban/vitamin-K

Intracranial haemorrhage secondary to thrombocytopenia and lack of efficacy to eptacog-α and vitamin-K: case report

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Yu Q, et al. Fatal spontaneous intracranial hemorrhage in the setting of rivaroxaban-associated thrombocytopenia: Report of autopsy findings and review of the literature. American Journal of Clinical Pathology 150 (Suppl. 1): S59-S60, Oct 2018. Available from: URL: http://doi.org/10.1093/ajcp/aqy091.147 [abstract] - USA Yu Q, et al. Fatal spontaneous intracranial hemorrhage in the setting of rivaroxaban-associated thrombocytopenia: Report of autopsy findings and review of the literature. American Journal of Clinical Pathology 150 (Suppl. 1): S59-S60, Oct 2018. Available from: URL: http://​doi.​org/​10.​1093/​ajcp/​aqy091.​147 [abstract] - USA
Metadata
Title
Eptacog-alfa/rivaroxaban/vitamin-K
Intracranial haemorrhage secondary to thrombocytopenia and lack of efficacy to eptacog-α and vitamin-K: case report
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69897-3